Traws Pharma, Inc.
TRAW
$1.55
$0.021.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -166.52M | -140.79M | -137.05M | -18.16M | -18.95M |
| Total Depreciation and Amortization | 12.00K | 14.00K | 17.00K | 17.00K | 16.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 143.29M | 118.85M | 118.87M | 1.30M | 1.30M |
| Change in Net Operating Assets | -6.57M | -8.26M | -5.01M | -972.00K | -301.00K |
| Cash from Operations | -29.79M | -30.18M | -23.18M | -17.81M | -17.93M |
| Capital Expenditure | -- | 0.00 | -14.00K | -14.00K | -14.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -3.65M | -3.65M | -3.65M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.65M | -3.65M | -3.66M | -14.00K | -14.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 33.98M | 14.00M | 14.00M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 33.98M | 14.00M | 14.00M | -- | -- |
| Foreign Exchange rate Adjustments | -19.00K | -3.00K | -5.00K | -3.00K | 10.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 517.00K | -19.83M | -12.84M | -17.83M | -17.94M |